Measure of Acceptance of chRonic Visible sKin conditionS (MARKS)

Regional University Hospital Center (CHRU)

Status: Enrolling

Conditions: Psychological Well-Being; Social Segregation; Disease Acceptance; Acceptance of Visible Chronic Dermatological Disease

Treatments: Behavioral: Questionnaire

Study type: Observational

Funder types: Other

Identifiers

NCT06103903

MARKS

Details and patient eligibility

About

The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with a large number of patients (children, adolescents, adults) and their parents (depending on the composition of the family cluster), in a multicentric manner (for territorial representativeness).

Full description

The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with a large number of patients (children, adolescents, adults) and their parents (depending on the composition of the family cluster), in a multicentric manner (for territorial representativeness).

The investigator will screen the patients and give them a link to complete the questionnaire (according to the age), that includes a pre-scale of acceptation of 50-55 items.

Enrollment: 250 estimated patients

Sex: All

Ages: 6+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Targeted pathologies:

   • Flat angioma
   • Primary hypopigmentation and early vitiligo
   • Primary hyperpigmentation
   • Refractory alopecia areata or congenital alopecia

2. Persons concerned:

   • Children (≥ 6 years old) suffering from one of the aforementioned pathologies
   • Adults suffering from one of the above-mentioned pathologies
   • Parents of children suffering from one of the aforementioned pathologies
   • Parents of young adult patients if they live under the same roof

3. Oral agreement for each person (major/minor) and, where applicable, one of the holders of parental authority (minor)

Exclusion criteria

1. Secondary "marks" (post-inflammatory, post-medication, post-traumatic, etc.)
2. Major psychiatric disorders

Trial design

250 participants in 4 patient groups

Children aged 6-13 years

Description:

Children aged 6-13 years with a chronic skin visible disease

Treatment:

Behavioral: Questionnaire

Adolescents aged 14-17 years

Description:

Adolescents aged 14-17 years years with a chronic skin visible disease

Treatment:

Behavioral: Questionnaire

Adult patients

Description:

Adult patients aged 18 years and more with a chronic skin visible disease

Treatment:

Behavioral: Questionnaire

Parents of children aged 6 years and more

Description:

Parents of children aged 6 years and more with a chronic skin visible disease

Treatment:

Behavioral: Questionnaire